StockData
Lifevantage Corp logo

Lifevantage Corp (LFVN) stock

LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 20/3043% below fair value
$4.89+0.08 (+1.66%)

Close on Nov 19, 2026Market cap $61.26MP/E 12.2Yield 3.78%

Lifevantage gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Lifevantage's gross profit for the twelve months ending Jun 30, 2026 was $141.61M, down 22.9% year over year. For fiscal 2026 it was $141.61M, down 22.9% from the year before. Over ten years it grew -2.0% a year on average. The highest annual figure on record is $194.95M in fiscal 2020.

Annual gross profit

PeriodPeriod endValueChange
FY2026Jun 30, 2026$141.61M-22.9%
FY2025Jun 30, 2025$183.67M+15.7%
FY2024Jun 30, 2024$158.72M-6.6%
FY2023Jun 30, 2023$170.01M+1.0%
FY2022Jun 30, 2022$168.26M-7.5%
FY2021Jun 30, 2021$181.99M-6.6%
FY2020Jun 30, 2020$194.95M+3.7%
FY2019Jun 30, 2019$187.99M+11.7%
FY2018Jun 30, 2018$168.36M+1.4%
FY2017Jun 30, 2017$166.03M-3.8%
FY2016Jun 30, 2016$172.61M+6.3%
FY2015Jun 30, 2015$162.33M-10.2%
FY2014Jun 30, 2014$180.77M+5.4%
FY2013Jun 30, 2013$171.54M+58.6%
FY2012Jun 30, 2012$108.13M+227.6%
FY2011Jun 30, 2011$33.00M–

Quarterly gross profit

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$33.04M-25.0%
Q3 FY2026CQ1 2026Mar 31, 2026$34.54M-27.0%
Q2 FY2026CQ4 2025Dec 31, 2025$36.21M-33.6%
Q1 FY2026CQ3 2025Sep 30, 2025$37.82M+0.2%
Q4 FY2025CQ2 2025Jun 30, 2025$44.05M+13.2%
Q3 FY2025CQ1 2025Mar 31, 2025$47.33M+24.3%
Q2 FY2025CQ4 2024Dec 31, 2024$54.57M+34.5%
Q1 FY2025CQ3 2024Sep 30, 2024$37.72M-8.4%
Q4 FY2024CQ2 2024Jun 30, 2024$38.91M-9.8%
Q3 FY2024CQ1 2024Mar 31, 2024$38.07M-11.7%
Q2 FY2024CQ4 2023Dec 31, 2023$40.56M-3.2%
Q1 FY2024CQ3 2023Sep 30, 2023$41.18M-1.5%
Q4 FY2023CQ2 2023Jun 30, 2023$43.15M+3.7%
Q3 FY2023CQ1 2023Mar 31, 2023$43.12M+6.9%
Q2 FY2023CQ4 2022Dec 31, 2022$41.90M-1.4%
Q1 FY2023CQ3 2022Sep 30, 2022$41.83M-4.5%
Q4 FY2022CQ2 2022Jun 30, 2022$41.61M-7.5%
Q3 FY2022CQ1 2022Mar 31, 2022$40.35M-5.6%
Q2 FY2022CQ4 2021Dec 31, 2021$42.51M-12.9%
Q1 FY2022CQ3 2021Sep 30, 2021$43.79M-3.6%
Q4 FY2021CQ2 2021Jun 30, 2021$45.00M-9.9%
Q3 FY2021CQ1 2021Mar 31, 2021$42.75M-9.0%
Q2 FY2021CQ4 2020Dec 31, 2020$48.82M-4.3%
Q1 FY2021CQ3 2020Sep 30, 2020$45.43M-3.4%
Q4 FY2020CQ2 2020Jun 30, 2020$49.92M+7.4%
Q3 FY2020CQ1 2020Mar 31, 2020$46.98M+0.5%
Q2 FY2020CQ4 2019Dec 31, 2019$51.01M+5.5%
Q1 FY2020CQ3 2019Sep 30, 2019$47.04M+1.4%
Q4 FY2019CQ2 2019Jun 30, 2019$46.46M+1.1%
Q3 FY2019CQ1 2019Mar 31, 2019$46.74M+12.2%
Q2 FY2019CQ4 2018Dec 31, 2018$48.37M+19.8%
Q1 FY2019CQ3 2018Sep 30, 2018$46.41M+14.9%
Q4 FY2018CQ2 2018Jun 30, 2018$45.96M+10.1%
Q3 FY2018CQ1 2018Mar 31, 2018$41.64M+13.2%
Q2 FY2018CQ4 2017Dec 31, 2017$40.37M-2.6%
Q1 FY2018CQ3 2017Sep 30, 2017$40.39M-12.3%
Q4 FY2017CQ2 2017Jun 30, 2017$41.75M–
Q3 FY2017CQ1 2017Mar 31, 2017$36.77M–
Q2 FY2017CQ4 2016Dec 31, 2016$41.45M–
Q1 FY2017CQ3 2016Sep 30, 2016$46.06M–

More Lifevantage figures

See a number that looks wrong?